*AstraZeneca Pharma India Ltd.* | *CMP* Rs. 7965 | *M Cap* Rs. 19913 Cr | *52 W H/L* 9199/5416 (Nirmal Bang Retail Research) *Result has improved* Revenue from Operations came at Rs. 480.5 Cr (9.1% QoQ, 25.4% YoY) vs QoQ Rs. 440.3 Cr, YoY Rs. 383.2 Cr EBIDTA came at Rs. 86.4 Cr (12.2% QoQ, 74.9% YoY) vs QoQ Rs. 77 Cr, YoY Rs. 49.4 Cr EBITDA Margin came at 18% vs QoQ 17.5%, YoY 12.9% Adj. PAT came at Rs. 58.3 Cr vs QoQ Rs. 64.4 Cr, YoY Rs. 39.5 Cr Quarter EPS is Rs. 23.3 Stock is trading at P/E of 96.3x TTM EPS